Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms

Background: Neuroendocrine neoplasms are a group of tumors deriving from neural crest. They can be located in every tissue, but most commonly in gastrointestinal tract. Targeted therapy with use of radionuclides is an available and acceptable way of treatment, but its long-term safety is still to be...

Full description

Bibliographic Details
Main Authors: Marek Saracyn, Adam Daniel Durma, Barbara Bober, Maciej Kołodziej, Arkadiusz Lubas, Waldemar Kapusta, Stanisław Niemczyk, Grzegorz Kamiński
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/15/1/185